A detailed history of State Street Corp transactions in Rx Sight, Inc. stock. As of the latest transaction made, State Street Corp holds 817,671 shares of RXST stock, worth $36.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
817,671
Previous 755,322 8.25%
Holding current value
$36.6 Million
Previous $45.4 Million 11.07%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$40.78 - $57.04 $2.54 Million - $3.56 Million
62,349 Added 8.25%
817,671 $40.4 Million
Q2 2024

Aug 14, 2024

BUY
$50.42 - $64.29 $4.24 Million - $5.4 Million
84,039 Added 12.52%
755,322 $45.4 Million
Q1 2024

May 15, 2024

SELL
$35.51 - $57.92 $1.16 Million - $1.89 Million
-32,684 Reduced 4.64%
671,283 $34.6 Million
Q4 2023

Feb 14, 2024

BUY
$20.91 - $40.9 $125 - $245
6 Added 0.0%
703,967 $28.4 Million
Q3 2023

Nov 14, 2023

BUY
$27.05 - $33.37 $6.87 Million - $8.48 Million
254,081 Added 56.48%
703,961 $19.6 Million
Q2 2023

Aug 14, 2023

BUY
$16.37 - $28.9 $1.34 Million - $2.37 Million
81,959 Added 22.28%
449,880 $13 Million
Q1 2023

May 15, 2023

BUY
$12.58 - $16.68 $929,272 - $1.23 Million
73,869 Added 25.12%
367,921 $6.14 Million
Q4 2022

Feb 14, 2023

BUY
$9.93 - $14.2 $30,236 - $43,239
3,045 Added 1.05%
294,052 $3.73 Million
Q3 2022

Nov 15, 2022

BUY
$11.19 - $15.85 $42,130 - $59,675
3,765 Added 1.31%
291,007 $3.49 Million
Q2 2022

Aug 15, 2022

BUY
$10.61 - $16.66 $1.44 Million - $2.26 Million
135,935 Added 89.84%
287,242 $4.04 Million
Q1 2022

May 16, 2022

BUY
$8.97 - $14.03 $391,298 - $612,030
43,623 Added 40.51%
151,307 $1.87 Million
Q4 2021

Feb 14, 2022

BUY
$9.52 - $13.81 $164,762 - $239,009
17,307 Added 19.15%
107,684 $1.21 Million
Q3 2021

Nov 15, 2021

BUY
$11.85 - $17.32 $1.07 Million - $1.57 Million
90,377 New
90,377 $1.15 Million

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.24B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.